Figure S1. Gating strategy y of EBER + sIgA + B l lymphocy ytes and FM MO contro ol. G (A) Initial gate was set on lymphocytes in the forward scatter (FSC) versus side scatter (SSC) dot plot. (B) Live cells were identified using Fixable Viability Dye. (C) CD19 + B cells were selected. (D) Cell doublets were excluded using FSC-A vs FSC-H characteristics. (E) EBER + B lymphocytes or (F) EBER + sIgA + B lymphocytes were identified. Numbers indicate percentage of paternal population. In total of 2x10 6 events measured, 115 EBER + B lymphocytes were identified according to suggested strategy for rare population identification. All gates were set based on FMO (Fluorochrome minus one) controls. (G) Gating strategy based on FMO controls. Gates of EBERpositive CD19 + cells, sIgA + CD19 + B cells, sIgG + CD19 + cells and sIgM + CD19 + cells were settled by fluorochrome minus one (FMO) controls.
Fig. 1C Distribution of EBV-infected cells according to sIg isotypes
IgAN Non-IgAN HC sIg+ EBER+ / total CD19+ cells [0.01%] IgA IgG IgM IgD IgA IgG IgM IgD IgA IgG IgM IgD 4±5 2±2 2±1 0.4±0.2 0.2±0.2 0.7±0.8 0.8±0.99 0.1±0.1 0.4±0.2 0.5±0.6 1.2±1 0.1±0.1
Fig. 1D Percentages of EBV positivity within individual populations of sIg+ cells

